Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/96929 |
Resumo: | A ketogenic diet is an important therapy used in the control of drug-refractory seizures. Many studies have shown that children and adolescents following ketogenic diets exhibit an over 50% reduction in seizure frequency, which is considered to be clinically relevant. These benefits are based on a diet containing high fat (approximately 90% fat) for 24 months. This dietary model was proposed in the 1920s and has produced variable clinical responses. Previous studies have shown that the mechanisms underlying seizure control involve ketone bodies, which are produced by fatty acid oxidation. Although the pathways involved in the ketogenic diet are not entirely clear, the main effects of the production of ketone bodies appear to be neurotransmitter modulation and antioxidant effects on the brain. This review highlights the impacts of the ketogenic diet on the modulation of neurotransmitters, levels of biogenic monoamines and protective antioxidant mechanisms of neurons. In addition, future perspectives are proposed. |
id |
USP-19_f378d9e92efbdfb4a3afd35bbfb2f7c7 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/96929 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy A ketogenic diet is an important therapy used in the control of drug-refractory seizures. Many studies have shown that children and adolescents following ketogenic diets exhibit an over 50% reduction in seizure frequency, which is considered to be clinically relevant. These benefits are based on a diet containing high fat (approximately 90% fat) for 24 months. This dietary model was proposed in the 1920s and has produced variable clinical responses. Previous studies have shown that the mechanisms underlying seizure control involve ketone bodies, which are produced by fatty acid oxidation. Although the pathways involved in the ketogenic diet are not entirely clear, the main effects of the production of ketone bodies appear to be neurotransmitter modulation and antioxidant effects on the brain. This review highlights the impacts of the ketogenic diet on the modulation of neurotransmitters, levels of biogenic monoamines and protective antioxidant mechanisms of neurons. In addition, future perspectives are proposed. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2014-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/9692910.6061/clinics/2014(10)09Clinics; Vol. 69 No. 10 (2014); 699-705Clinics; v. 69 n. 10 (2014); 699-705Clinics; Vol. 69 Núm. 10 (2014); 699-7051980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/96929/96009Copyright (c) 2015 Clinicsinfo:eu-repo/semantics/openAccessLima, Patricia Azevedo de Sampaio, Leticia Pereira de Brito Damasceno, Nágila Raquel Teixeira 2015-03-27T17:35:39Zoai:revistas.usp.br:article/96929Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2015-03-27T17:35:39Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy |
title |
Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy |
spellingShingle |
Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy Lima, Patricia Azevedo de |
title_short |
Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy |
title_full |
Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy |
title_fullStr |
Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy |
title_full_unstemmed |
Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy |
title_sort |
Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy |
author |
Lima, Patricia Azevedo de |
author_facet |
Lima, Patricia Azevedo de Sampaio, Leticia Pereira de Brito Damasceno, Nágila Raquel Teixeira |
author_role |
author |
author2 |
Sampaio, Leticia Pereira de Brito Damasceno, Nágila Raquel Teixeira |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Lima, Patricia Azevedo de Sampaio, Leticia Pereira de Brito Damasceno, Nágila Raquel Teixeira |
description |
A ketogenic diet is an important therapy used in the control of drug-refractory seizures. Many studies have shown that children and adolescents following ketogenic diets exhibit an over 50% reduction in seizure frequency, which is considered to be clinically relevant. These benefits are based on a diet containing high fat (approximately 90% fat) for 24 months. This dietary model was proposed in the 1920s and has produced variable clinical responses. Previous studies have shown that the mechanisms underlying seizure control involve ketone bodies, which are produced by fatty acid oxidation. Although the pathways involved in the ketogenic diet are not entirely clear, the main effects of the production of ketone bodies appear to be neurotransmitter modulation and antioxidant effects on the brain. This review highlights the impacts of the ketogenic diet on the modulation of neurotransmitters, levels of biogenic monoamines and protective antioxidant mechanisms of neurons. In addition, future perspectives are proposed. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/96929 10.6061/clinics/2014(10)09 |
url |
https://www.revistas.usp.br/clinics/article/view/96929 |
identifier_str_mv |
10.6061/clinics/2014(10)09 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/96929/96009 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2015 Clinics info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2015 Clinics |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 69 No. 10 (2014); 699-705 Clinics; v. 69 n. 10 (2014); 699-705 Clinics; Vol. 69 Núm. 10 (2014); 699-705 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222761673555968 |